Good Response to Paclitaxel Predicts High Rates of Pathologic Complete Response for Breast Cancer Patients Treated Preoperatively with Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide

Publisher: Karger

E-ISSN: 1423-0232|77|2|134-139

ISSN: 0030-2414

Source: Oncology, Vol.77, Iss.2, 2009-07, pp. : 134-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract